Navigation Links
InVitria's Cellastim Showcased in Nature Article
Date:10/7/2008

FORT COLLINS, Colo., Oct. 7 /PRNewswire/ -- A study published in the scientific journal Nature examining embryonic stem cell self-renewal, reported that InVitria's (http://www.InVitria.com) Cellastim (recombinant human serum albumin) was an effective replacement to bovine serum albumin in ES-cell culture.

The article entitled, "The ground state of embryonic stem cell self-renewal," disclosed that researchers used Cellastim as a recombinant albumin in place of animal-derived serum to eliminate contaminants in the cell culture. The Cellastim was a contributing factor in the enhancement of bulk passaging and clonal propagation (1).

"This study further supports the use of InVitria's Cellastim as an enhancement to cell culture media," said InVitria President Scott Deeter. "Cellastim is the only supplement available that not only improves cell culture performance, but does so while maintaining a defined and animal free media."

About InVitria (http://www.InVitria.com)

InVitria has developed cell culture ingredients that enhance productivity, safety and time to market for companies in the biopharmaceutical, cell culture, regenerative medicine, life science research and diagnostics industry. Cellastim is used to enhance cell growth and productivity. It is animal component free and has been used as a cell culture ingredient in regenerative medicine, mammalian cell culture media, stem cell media and primary cell media. (See http://www.Cellastim.com)

For more information about the InVitria line of products, please e-mail info@InVitria.com or call 1-800-916-8311.

(1) Ying, Q.L.et al. The ground state of embryonic stem cell self- renewal. Nature 453, 519-524 (May 2008).


'/>"/>
SOURCE InVitria
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
2. Brain Signature for Cigarette Cravings Identified
3. Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics
4. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
5. Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling
6. Targeted Nanoparticles Offer Promise in the Battle Against Cancer
7. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
8. Tumor Eradication Article Published by Cancer Research
9. Recent Findings from the Framingham Offspring Study Show Low Numbers of LDL Particles (LDL-P) by NMR are Associated With Fewer Heart Disease Related Events than Equivalently Low Levels of LDL Cholesterol (LDL-C).(1)
10. Clinical Trial Participation Unaffected by Disclosure of Investigators Financial Stake, Food and Drug Law Journal Article Finds
11. Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2017)... , Sept. 18, 2017 ... fields of bioinformatics and immune engineering, today ... protective avian influenza A (H7N9) vaccine. ... related to seasonal influenza and presents a ... on prior exposure to be effective. Using ...
(Date:9/12/2017)... NEW YORK , Sept. 12, 2017   EcoVadis , ... supply chains, has published the first annual edition of its Global CSR ... than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings that analyzed ... ... & Performance Index ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., the ... (VLMS), is pleased to announce the appointment of ... of its Board of Directors and Chairman of ... enables life science companies to manage their entire ... of paper in this process. Furthermore, ValGenesis VLMS ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 2017 , ... Many families have long-term insurance that covers care for a ... waiver for care if the client has a cognitive impairment diagnosis. , “What ... is often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... viewers the lowdown on sciatica in a new episode of "Success Files," which ... current events and innovation and investigates each subject in-depth with passion and integrity. ...
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a ... health care, have expanded their existing home health joint venture through an agreement, ... been operating a joint venture home health company with Asante, delivering clinically integrated ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the ... – Miles by Moonlight to raise money for the American Heart Association Heart Walk. ... , Teams will work together to keep their treadmills moving for 5 hours. Treadmills ...
Breaking Medicine News(10 mins):